Showing 1 - 12 results of 12 for search 'The present study was supported by: the DHOF program of the UMR5244/IHPE (http://ihpe.univ-perp.fr/en/ihpe-transversal-holobiont/); the Ifremer project HémoMicrobiote; EMBRC-France, whose French state funds are managed by the ANR within the Investments of the Future (ANR-10-INBS-02); the ANR projects DECIPHER (ANR-14-CE19–0023) and ENVICOPAS (ANR-15-CE35–0004); the EU funded project VIVALDI (H2020 program, n°678589); by Ifremer; CNRS, Université de Montpellier; Université de Perpignan via Domitia; by the IHU Méditerranée Infection, Marseille, France, by the French Government under the «Investissements d’avenir» program (reference: Méditerranée Infection 10-IAHU-03) and by the Région Provence-Alpes-Côte d’Azur and by the European funding FEDER PRIMI. This study is set within the framework of the “Laboratoires d’Excellences (LABEX)” TULIP (ANR-10-LABX-41).'Skip to content
Search Results
Showing 1 - 12 results of 12 for search 'The present study was supported by: the DHOF program of the UMR5244/IHPE (http://ihpe.univ-perp.fr/en/ihpe-transversal-holobiont/); the Ifremer project HémoMicrobiote; EMBRC-France, whose French state funds are managed by the ANR within the Investments of the Future (ANR-10-INBS-02); the ANR projects DECIPHER (ANR-14-CE19–0023) and ENVICOPAS (ANR-15-CE35–0004); the EU funded project VIVALDI (H2020 program, n°678589); by Ifremer; CNRS, Université de Montpellier; Université de Perpignan via Domitia; by the IHU Méditerranée Infection, Marseille, France, by the French Government under the «Investissements d’avenir» program (reference: Méditerranée Infection 10-IAHU-03) and by the Région Provence-Alpes-Côte d’Azur and by the European funding FEDER PRIMI. This study is set within the framework of the “Laboratoires d’Excellences (LABEX)” TULIP (ANR-10-LABX-41).', query time: 0.40s
Refine Results